Does anyone have an opinion on PRM.
No comparable news for a while.
Price seems to be sliding once again.

I think they need to empty the fridges in the executive suite wherever they sleep.
(that's where the smell is)
Good to read that Share-Options are still considered part of Exec. pay . . . . . . .........Grr.
(This stock has lost 2/3 value since 2007 - DYOR -) - 24p mid today on small trades, nearly even despite a 10% push by MM's.
EDIT (20Nov2010)- SP has risen, presumably a few months of no bad News - we needed it!, now 36p-ish DYOR.
EDIT (11Feb2011) -slipped to 34p after a rise, due to Jan Contract win.
EDIT (5Sept2013)-; Yawn,- Peaked 70p 2013 now dn at 46p . . . oh deary, how dreary . . .
((EDIT))Dec2016...Looking back 10years - easily 90% Club - it's now 5.5p

Thought I'd post again . . . but nowt to say - this Co. is a thorough disappointment.
27p-ish
EDIT Jan2017 - now about 5p. . . . hopeless.

Some good news today and rising from a very low point now 42.25p

28 June 2013 AGM

Proteome Sciences expects a sharp increase in group revenue in 2013, the company's annual general meeting statement says.

The group says its commercial activities are benefiting from its technology development and the rapid increase in the numbers of biomarkers covered by its assays that doubled to over 100 in 2012.

It says SysQuant cell signalling pathway assays introduced this year will extend these further and should make a considerable contribution to the assay portfolio. This is reflected in biomarker services in revenue particularly through the major strategic contract announced earlier this month and through a broad and growing pipeline of contracts, enquiries and quotations.

Proteome Sciences says licensing discussions are expected to benefit from the excellent results coming through this year from CK1D that will be presented at the main Alzheimer's meeting in July, strongly supported by the considerable improvement in performance from two new peptide panels announced in the preliminary results for Alzheimer's disease and mild cognitive impairment (MCI), with further developments anticipated from our stroke biomarkers.

Outstanding data was presented at the June ASMS meeting using TMT which now appears to be established as the reagent of choice for key opinion leaders in the field. The growing range of products and applications should accelerate and convert more widely the use of TMT into mainstream biology and additional revenue. Proteome Sciences says it has again been made aware of certain speculative and inappropriate comments regarding its US biomarker patent portfolio in the light of recent US court rulings on patent eligibility, in particular the court's recent ruling against Myriad that patents will not be allowed on genes.

Proteome Sciences says this has no bearing on the company's intellectual property.

And it says shareholders will be pleased to know that the company received subsequent notification this week from the US Patent and Trademark Office of the allowance of a new patent in Huntington's disease.

It adds: "We conclude that these decisions do not change the status of our issued and pending US applications or impact our granted US patents which continue to remain in good standing.

"We expect a strong performance over the year from licences, products and services as we continue to raise our corporate and research profile and this should lead to a sharp increase in Group revenue in 2013."

I have gone grey waiting for the sharp rise in revenue to beat the even sharper rise in losses!

It seems that Alzheimers could be detected 10 years before the symptoms appear if suitable biomarkers are employed. I gather that the Government are keen to fund the
work as ,although there is no cure yet available,the dementia can be largely mitigated
if found soon enough.Cameron has just doubled the grants available.I had to look after my father for 6 years of dementia and I really hope I am not going down that road.
I am back in.

What would be the point of detecting Az 10 years beforehand? - And how do they know? Surely the body is so complex you could die of something else and then the detection would be - pointless. Of course if it was cheap, then maybe - but I don't know the price-point of these "markers" - and I suspect they aren't cheap.
Anyone know?

The trouble with this co (investment) appears to be that investors never benefit from all this good medicine. As to Government being keen - I discount this as Political posturing - otherwise they'd be spending money - but the mantra of NHS is to Cut, Cut, Cut - so I don't see where PRM is going to get acceptable income from UK/NHS.
This co. is a serial disappointment IMHO.
EDIT: (25March2014)...35p &+ve movement, but recent ( Feb14), Placing at 28p was a further blow to earlier investors. I see CP has bought 4m shares since 2008.
EDIT (Oct2014) Looks like Mr Diggle likes this company as well as OXB - appears to have LT investment for his Life-Sciences fund....DYOR. sp now 31p
EDIT ( 20Jan2015 ) NHS cuts cancer-drug funding for patients, PRM sp 25p
EDIT (31March2015)- earlier iin March more agreements signed-plus US Patent granted -DYOR- sp is 19p - Oh deary..... where's the money?
EDIT (2June2015 )-Oh deary, looks like 2014-Sales barely £1m and losses stack up to £60m - DYOR - looks pretty thin for Investor returns.... yet-awhile.
EDIT-(24May2016)- New CEO for June16 maybe reverse fortune...fell 9% to 17p.
EDIT(1Nov2016)-Bad Summer. PRM rose today to 6p. Oh deary.
EDIT(2Nov2016) -£3.2m@5p Rights-Huh- Why the slide is now revealed. It's 22% dilution-The timescale appears rushed... Anyone?
EDIT(30Dec2016)-Big Ann re Website - pres wh they've been spending investor money and PRM-management effort . . . www.proteomics.com. - does not work...Error msg 404 . . . what a waste of effort.... Wake Up PRM to the real World - and earn us some money from the trust we placed. sp 5.5p
EDIT (24April2017)- missed the AGM, because they don't send the paperwork any more . . . must have known it would be of little interest, etc. sp 5.5 could be worse? - at lest theior website is OK, but no mention of AGM, yesterday.
EDIT (30May2017)- sp down today (on small Vulpes Investment buy?) = 4.8p
EDIT (25July2017) - sp down 17% ( now 3.72p ). Management thinks results are in line...etc. Loss this time is 50k better than last. Oh dear.
EDIT (28July2017)-sp 3.6p...... Half-year results RNS [DYOR]:- T/O (similar to large corner-shop ), is smaller than losses, again - does no-one want this stuff?
EDIT:(7Nov2017)_ I mean their Testing-kits...or whatever..... BUT, there is the issue...as I find it difficult to say exactly "What" they are trying to sell.... Oh Dear.
Makes you want to weep, eh?
EDIT (6Jan2018)- down on Results, 2p8 - doesn't look good at all.

Listen: Proteome Science (PRM) - Preliminary results

Click here to listen

EDIT ( 18April2018) - RNS=extended agreement with subsidiary of ThermoFisherInc - but clearly the income from these deals is close to zippo... ( with current sp about 3p...DYOR.) . Relying on one Sales outlet is BAD News, as it makes you vulnerable to takeover at low price.....Oh and that's where we are.. .Oops! All IMHO.
EDIT (3May2018)- sp still ~3p - note that Martin Diggle has bought 100,000 shares DYOR towards end of 2017 - but no-one else believes this Co is going anywhere. I don't like reliance on one major outlet . . . surely if the stuff's good every Medic will want it?
EDIT(6Dec2018)- sp 3.55 (down 8%)...\ Co. News is Dir buying earlier in 2018. No chance this business will pick up. BTW they sell testing stuff for others to make Drug Discoveries - seems like they need a Division to develop something like..... . . ? Instead of waiting for Others - and who are these others?